proteogenix 产品代理

产品分类 > 临床研究 > proteogenix 产品代理

proteogenix 产品代理

2003年,ProteoGenix公司创立之初的想法是开发诊断分析和生物疗法,以其创始人发现的蛋白质为目标。管理层很快理解了高质量抗体和蛋白质对于开发生物制药产品以及随后进入难以到达的临床环境的难以置信的价值。

事实上,生物分子的特征预先决定了它们克服困难障碍和陷阱的能力,而这些障碍和陷阱往往会在通往诊所的路上随处可见。ProteoGenix与生命科学界分享其治疗性抗体和定制检测经验的想法很快获得了支持。作为主要的CRO和最受欢迎的生物制药合作伙伴,ProteoGenix为显著提高生物分子进入IND应用的成功率而感到自豪。

价格: 0.00

Therapeutic Antibody

Antibody Production

Protein Expression

Bioproduction

Bioanalytics

Gene Synthesis

Peptide Synthesis

Custom Assay

Research Products

Request a Quote

Book a call



In 2003, ProteoGenix was started with the idea of developing diagnostic assays and biotherapeutics to target proteins discovered by its founders. The management quickly understood the incredible value of high quality antibodies and proteins for developing biopharma products and subsequently gaining access to the difficult-to-reach clinic setting.

 

Indeed, the features of the biomolecules developed predetermine their capacity to overcome the difficult obstacles and pitfalls that often litter the way to the clinic. ProteoGenix’ idea of sharing its experience in therapeutic antibodies and custom assays with the life science community quickly gained ground. As a major CRO and favorite biopharma partner, ProteoGenix is proud of having significantly improved the success rate of biomolecules reaching the IND application.

 

As a service integrator, we guide our customers from early discovery to the clinic. Our main objective is to anticipate future requirements of biomolecules from the very beginning and to subsequently design a suitable development strategy. This means providing an extensive range of innovative solutions and technologies. Thus, with more than 15 years of experience and a solid international standing, we offer unique and customized access to 6 areas of complementary services, structured around:

 

Antibody engineering (Humanization, Bi-specific, ADC, affinity maturation, molecule optimization)

Bioprocess development (IP free stable cell line development, fermentation and bioreactor production optimization)

Monoclonal and polyclonal antibody development (Hybridoma method and Phage Display)

Recombinant protein and antibody production (E. coli, B. subtilis, Yeast, Insect cells, Mammalian cells)

Gene synthesis

Peptide synthesis

Our R&D labs constantly influence our processes with outstanding innovations like XtenCHO™ (a cell line for transient expression exceeding ExpiCHO’s productivity performance).

 

We have also developed an extensive catalog of 200,000+ products, which are available in our online shop and located easily using our efficient search engine. It brings together antibodies, proteins, ELISA kits, cell separation media, nucleic acid purification kits…


上一个: Proteos 产品代理